神经性厌食症与新型冠状病毒肺炎感染：临床病例报告
Anorexia nervosa and COVID-19 infection: Clinical case report.
作者信息
Simeunovic-Ostojic Mladena, Herremans Evy E, Thai Khoa, Maas Joyce
机构信息
Center for Eating Disorders Helmond Mental Health Center Region Oost-Brabant Boekel The Netherlands.
Star-shl Medical Diagnostic Center Rotterdam The Netherlands.
出版信息
Clin Case Rep. 2022 Sep 2;10(9):e6216. doi: 10.1002/ccr3.6216. eCollection 2022 Sep.
Abstract
The true risk of COVID-19 infection in anorexia nervosa (AN) including the duration of viral RNA shedding and infectivity is still unclear. We report on a case of a patient with severe AN with a mild course of COVID-19 and prolonged viral RNA shedding for at least 39 days after symptom onset. A careful evaluation of long-term infectivity must include viral load, live virus isolation, and viral genome sequencing.
摘要
神经性厌食症（AN）患者感染新型冠状病毒肺炎（COVID-19）的真实风险，包括病毒RNA脱落持续时间和传染性，目前仍不清楚。我们报告了1例患有严重AN的患者，其COVID-19病程较轻，但症状出现后病毒RNA脱落延长至少39天。对长期传染性的仔细评估必须包括病毒载量、活病毒分离和病毒基因组测序。
相似文献
1
Anorexia nervosa and COVID-19 infection: Clinical case report.神经性厌食症与新型冠状病毒肺炎感染：临床病例报告
Clin Case Rep. 2022 Sep 2;10(9):e6216. doi: 10.1002/ccr3.6216. eCollection 2022 Sep.
2
Dynamics of Viral Shedding and Symptoms in Patients with Asymptomatic or Mild COVID-19.无症状或轻症 COVID-19 患者的病毒脱落和症状动力学。
Viruses. 2021 Oct 22;13(11):2133. doi: 10.3390/v13112133.
3
SARS-CoV-2 detection, viral load and infectivity over the course of an infection.在感染过程中对 SARS-CoV-2 的检测、病毒载量和传染性。
J Infect. 2020 Sep;81(3):357-371. doi: 10.1016/j.jinf.2020.06.067. Epub 2020 Jun 29.
4
Trends in the Incidence of New-Onset Anorexia Nervosa and Atypical Anorexia Nervosa Among Youth During the COVID-19 Pandemic in Canada.加拿大 COVID-19 大流行期间青年新发神经性厌食症和非典型神经性厌食症发病率的趋势。
JAMA Netw Open. 2021 Dec 1;4(12):e2137395. doi: 10.1001/jamanetworkopen.2021.37395.
5
Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series.《COVID-19 中的每日病毒动力学和固有及适应性免疫反应评估：病例系列》。
mSphere. 2020 Nov 11;5(6):e00827-20. doi: 10.1128/mSphere.00827-20.
6
The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody.评估在接受抗 CD20 抗体治疗的 B 细胞淋巴瘤 COVID-19 患者中，使用抗 SARS-CoV-2 单克隆抗体和长期使用抗病毒药物期间，病毒持续脱落的风险因素。
BMC Infect Dis. 2024 Jul 22;24(1):715. doi: 10.1186/s12879-024-09631-3.
7
Evaluation of In-Hospital Cluster of COVID-19 Associated With a Patient With Prolonged Viral Shedding Using Whole-Genome Sequencing.利用全基因组测序评估与病毒持续排出相关的 COVID-19 院内聚集性感染。
J Korean Med Sci. 2022 Oct 10;37(39):e289. doi: 10.3346/jkms.2022.37.e289.
8
SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis.SARS-CoV-2、SARS-CoV 和 MERS-CoV 的病毒载量动态、病毒脱落持续时间和传染性：系统评价和荟萃分析。
Lancet Microbe. 2021 Jan;2(1):e13-e22. doi: 10.1016/S2666-5247(20)30172-5. Epub 2020 Nov 19.
9
Trajectory of Viral RNA Load Among Persons With Incident SARS-CoV-2 G614 Infection (Wuhan Strain) in Association With COVID-19 Symptom Onset and Severity.SARS-CoV-2 G614 感染（武汉株）患者新冠病毒载量随症状出现和严重程度的变化轨迹。
JAMA Netw Open. 2022 Jan 4;5(1):e2142796. doi: 10.1001/jamanetworkopen.2021.42796.
10
Factors associated with prolonged viral shedding and impact of lopinavir/ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection.与 SARS-CoV-2 感染住院非重症患者病毒持续排出相关因素及洛匹那韦/利托那韦治疗的影响。
Eur Respir J. 2020 Jul 16;56(1). doi: 10.1183/13993003.00799-2020. Print 2020 Jul.
本文引用的文献
1
COVID-19 infection and body weight: A deleterious liaison in a J-curve relationship.COVID-19 感染与体重：呈 J 型曲线关系的有害关联。
Obes Res Clin Pract. 2021 Nov-Dec;15(6):523-535. doi: 10.1016/j.orcp.2021.10.006. Epub 2021 Nov 3.
2
The Longest Infectious Virus Shedding in a Child Infected With the G614 Strain of SARS-CoV-2.感染 SARS-CoV-2 G614 株的儿童最长的传染性病毒脱落。
Pediatr Infect Dis J. 2021 Jul 1;40(7):e263-e265. doi: 10.1097/INF.0000000000003158.
3
The J-shaped relationship between body mass index and mortality in patients with COVID-19: A dose-response meta-analysis.新冠病毒肺炎患者体重指数与死亡率之间的J形关系：一项剂量反应荟萃分析。
Diabetes Obes Metab. 2021 Jul;23(7):1701-1709. doi: 10.1111/dom.14382. Epub 2021 Apr 14.
4
Body Mass Index and Risk for COVID-19-Related Hospitalization, Intensive Care Unit Admission, Invasive Mechanical Ventilation, and Death - United States, March-December 2020.体重指数与 2020 年 3 月至 12 月期间 COVID-19 相关住院、重症监护病房收治、有创机械通气和死亡风险的关系-美国。
MMWR Morb Mortal Wkly Rep. 2021 Mar 12;70(10):355-361. doi: 10.15585/mmwr.mm7010e4.
5
Streamlining SARS-CoV-2 confirmatory testing to reduce false positive results.优化新型冠状病毒2型（SARS-CoV-2）确证检测以减少假阳性结果。
J Clin Virol. 2021 Mar;136:104762. doi: 10.1016/j.jcv.2021.104762. Epub 2021 Feb 11.
6
Smell and taste disorders in COVID-19: From pathogenesis to clinical features and outcomes.新型冠状病毒肺炎相关的嗅觉和味觉障碍：从发病机制到临床特征和结局。
Neurosci Lett. 2021 Mar 23;748:135694. doi: 10.1016/j.neulet.2021.135694. Epub 2021 Feb 15.
7
Long-Term Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectiousness Among Three Immunocompromised Patients: From Prolonged Viral Shedding to SARS-CoV-2 Superinfection.长期严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）在 3 名免疫功能低下患者中的传染性：从延长的病毒脱落到 SARS-CoV-2 再感染。
J Infect Dis. 2021 May 20;223(9):1522-1527. doi: 10.1093/infdis/jiab075.
8
SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis.SARS-CoV-2、SARS-CoV 和 MERS-CoV 的病毒载量动态、病毒脱落持续时间和传染性：系统评价和荟萃分析。
Lancet Microbe. 2021 Jan;2(1):e13-e22. doi: 10.1016/S2666-5247(20)30172-5. Epub 2020 Nov 19.
9
COVID-19, anorexia nervosa and obese patients with an eating disorder - some considerations for practitioners and researchers.2019冠状病毒病、神经性厌食症以及患有饮食失调症的肥胖患者——给从业者和研究人员的一些思考
J Eat Disord. 2021 Jan 20;9(1):15. doi: 10.1186/s40337-021-00369-w.
10
Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19).COVID-19 住院患者中感染性病毒排出的持续时间和关键决定因素。
Nat Commun. 2021 Jan 11;12(1):267. doi: 10.1038/s41467-020-20568-4.
Zotero 插件